Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.5 EUR -11.19% Market Closed
Market Cap: 20.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Wall Street
Price Targets

CYAD Price Targets Summary
Celyad Oncology SA

There are no price targets for CYAD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Celyad Oncology SA Competitors:
Price Targets
300142
Walvax Biotechnology Co Ltd
16% Upside
HOWL
Werewolf Therapeutics Inc
497% Upside
4599
StemRIM Inc
101% Upside
RPTX
Repare Therapeutics Inc
329% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
28% Upside
BCYC
Bicycle Therapeutics PLC
73% Upside
FLUO
Fluoguide AS
303% Upside
VICO
Vicore Pharma Holding AB
262% Upside

Revenue
Forecast

Revenue Estimate
Celyad Oncology SA

For the last 8 years the compound annual growth rate for Celyad Oncology SA's revenue is 55%.

55%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Celyad Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Celyad Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYAD's stock price target?
Not Available

CYAD doesn't have any price targets made by Wall Street professionals.

Back to Top